
Over the last 7 days, the Medical Equipment industry has risen 1.2%, and Zylox-Tonbridge Medical Technology contributed the most with a gain of 3.4%. During this same period, the Shenzhen Edge Medical underperformed, falling 10%. This means that the industry has gained 25% over the past year. Looking forward, earnings are forecast to grow by 49% annually.
Has the Hong Kong Medical Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 14 Mar 2026 | HK$223.8b | HK$64.0b | HK$2.4b | 16.4x | 93.8x | 3.5x |
| Mon, 09 Feb 2026 | HK$237.4b | HK$63.5b | HK$2.3b | 18.4x | 101.5x | 3.7x |
| Wed, 07 Jan 2026 | HK$215.0b | HK$62.7b | HK$2.5b | 20.4x | 85.6x | 3.4x |
| Fri, 05 Dec 2025 | HK$216.8b | HK$63.3b | HK$3.1b | 19.4x | 70.1x | 3.4x |
| Sun, 02 Nov 2025 | HK$223.4b | HK$63.0b | HK$3.1b | 20.6x | 72.8x | 3.5x |
| Tue, 30 Sep 2025 | HK$221.2b | HK$62.9b | HK$3.0b | 20.6x | 74.5x | 3.5x |
| Thu, 28 Aug 2025 | HK$223.2b | HK$62.5b | HK$3.5b | 24.5x | 62.9x | 3.6x |
| Sat, 26 Jul 2025 | HK$214.6b | HK$62.0b | HK$3.2b | 20.9x | 66.5x | 3.5x |
| Mon, 23 Jun 2025 | HK$179.5b | HK$62.0b | HK$3.2b | 22x | 55.7x | 2.9x |
| Wed, 21 May 2025 | HK$167.8b | HK$61.6b | HK$3.2b | 22.1x | 52.6x | 2.7x |
| Fri, 18 Apr 2025 | HK$152.0b | HK$60.7b | HK$3.1b | 20.6x | 48.7x | 2.5x |
| Sun, 16 Mar 2025 | HK$171.1b | HK$58.6b | HK$577.8m | 21.6x | 296.1x | 2.9x |
| Tue, 11 Feb 2025 | HK$154.9b | HK$57.9b | HK$1.2b | 18.3x | 131.8x | 2.7x |
| Thu, 09 Jan 2025 | HK$129.8b | HK$57.7b | HK$1.2b | 18.6x | 111.8x | 2.3x |
| Sat, 07 Dec 2024 | HK$133.0b | HK$58.1b | HK$1.2b | 15.2x | 111.3x | 2.3x |
| Mon, 04 Nov 2024 | HK$134.8b | HK$58.8b | HK$1.3b | 15.7x | 106.3x | 2.3x |
| Wed, 02 Oct 2024 | HK$149.2b | HK$59.6b | HK$1.4b | 14.1x | 106.4x | 2.5x |
| Fri, 30 Aug 2024 | HK$118.3b | HK$55.3b | -HK$689,368,548.36 | 12.5x | -171.6x | 2.1x |
| Sun, 28 Jul 2024 | HK$118.2b | HK$54.0b | -HK$1,093,747,374.92 | 12.5x | -108.1x | 2.2x |
| Tue, 25 Jun 2024 | HK$126.0b | HK$54.0b | -HK$1,096,052,413.43 | 12.6x | -115x | 2.3x |
| Thu, 23 May 2024 | HK$153.1b | HK$54.0b | -HK$1,090,981,926.19 | 15.6x | -140.4x | 2.8x |
| Sat, 20 Apr 2024 | HK$141.7b | HK$54.2b | -HK$1,094,809,749.01 | 13.5x | -129.4x | 2.6x |
| Mon, 18 Mar 2024 | HK$155.0b | HK$52.7b | -HK$1,043,560,638.68 | 12.2x | -148.6x | 2.9x |
| Wed, 14 Feb 2024 | HK$151.3b | HK$53.2b | -HK$2,428,208,466.54 | 11.8x | -62.3x | 2.8x |
| Fri, 12 Jan 2024 | HK$184.5b | HK$53.6b | -HK$2,348,279,332.00 | 14.2x | -78.6x | 3.4x |
| Sun, 10 Dec 2023 | HK$195.2b | HK$53.5b | -HK$2,343,144,300.00 | 15.3x | -83.3x | 3.6x |
| Tue, 07 Nov 2023 | HK$217.0b | HK$53.1b | -HK$2,341,684,227.00 | 18.5x | -92.7x | 4.1x |
| Thu, 05 Oct 2023 | HK$209.2b | HK$52.9b | -HK$2,344,525,912.00 | 14.7x | -89.2x | 4x |
| Sat, 02 Sep 2023 | HK$218.6b | HK$53.1b | -HK$2,193,293,919.00 | 17x | -99.7x | 4.1x |
| Mon, 31 Jul 2023 | HK$257.0b | HK$51.2b | -HK$3,933,688,491.00 | 20.4x | -65.3x | 5x |
| Wed, 28 Jun 2023 | HK$239.9b | HK$51.1b | -HK$3,943,911,842.00 | 19.4x | -60.8x | 4.7x |
| Fri, 26 May 2023 | HK$262.1b | HK$51.9b | -HK$3,964,602,027.00 | 20.4x | -66.1x | 5.1x |
| Sun, 23 Apr 2023 | HK$302.3b | HK$53.1b | -HK$4,232,098,730.00 | 22.8x | -71.4x | 5.7x |
| Tue, 21 Mar 2023 | HK$276.7b | HK$54.5b | -HK$2,618,394,204.00 | 21x | -105.7x | 5.1x |
-105.7x
Which industries have driven the changes within the Hong Kong Healthcare industry?
| HK Market | -0.32% | |
| Healthcare | -2.34% | |
| Medical Equipment | -3.16% | |
| Medical Equipment | -2.84% | |
| Medical Supplies | -3.88% | |
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 2190 Zylox-Tonbridge Medical Technology | HK$21.36 | 3.4% +HK$236.1m | 50.8% | PE41.6x | |
| 2172 MicroPort NeuroScientific | HK$11.47 | 3.2% +HK$207.3m | -7.6% | PE28.6x | |
| 1302 LifeTech Scientific | HK$1.74 | 2.4% +HK$185.3m | 6.1% | PE98.7x | |
| 6609 Shanghai HeartCare Medical Technology | HK$46.66 | 10.3% +HK$165.1m | 44.9% | PE36.7x | |
| 6929 OrbusNeich Medical Group Holdings | HK$3.82 | 5.5% +HK$164.8m | -0.8% | PE9.6x |